|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS12200 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 ICC=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-SEMA4A |
| 克隆性 | 是 |
| 靶點(diǎn) | 詳見(jiàn)說(shuō)明書(shū) |
| 適應(yīng)物種 | 詳見(jiàn)說(shuō)明書(shū) |
| 形態(tài) | 詳見(jiàn)說(shuō)明書(shū) |
| 宿主 | 詳見(jiàn)說(shuō)明書(shū) |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見(jiàn)說(shuō)明書(shū) |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated synthetic peptide derived from hu SEMA4A |
跨膜蛋白SEMA4A抗體說(shuō)明書(shū) 英文名稱 Anti-SEMA4A
中文名稱 跨膜蛋白SEMA4A抗體說(shuō)明書(shū)
別 名 CORD10; RP11 54H19 2; RP35; Sema B; Sema domain immunoglobulin domain Ig transmembrane domain TM and short cytoplasmic domain 4A; Sema domain immunoglobulin domain Ig transmembrane domain TM and short cytoplasmic domain semaphorin 4A ; SEMAB; Semaphorin 4A precursor; Semaphorin B; SEMB.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Pig, Cow, Rabbit
產(chǎn)品類型 一抗
研究領(lǐng)域 心 細(xì)胞生物 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo)
蛋白分子量 predicted molecular weight: 80kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from hu SEMA4A
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4
跨膜蛋白SEMA4A抗體說(shuō)明書(shū) 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:100-500 ICC=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 SEMA4A belongs to the semaphorin family of soluble and transmembrane proteins. These proteins play a role in guidance of axonal migration during neuronal development and in immune responses.
Function : Cell surface receptor for PLXNB1, PLXNB2, PLXNB3 and PLXND1 that plays an important role in cell-cell signaling. Plays a role in priming antigen-specific T cells, promotes differentiation of Th1 T helper cells, and thereby contributes to adaptive immunity. Promotes phosphorylation of TIMD2. Inhibits angiogenesis. Promotes axon growth cone collapse. Inhibits axonal extension by providing local signals to specify territories inaccessible for growing axons (By similarity).
Subunit : Interacts with PLXNB1, PLXNB2, PLXNB3 and PLXND1. Probable ligand for TIMD2.
Subcellular Location : Cell membrane; Single-pass type I membrane protein.
DISEASE : Defects in SEMA4A are the cause of retinitis pigmentosa type 35 (RP35) [MIM:610282]. RP leads to degeneration of retinal photoreceptor cells. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
Defects in SEMA4A are the cause of cone-rod dystrophy type 10 (CORD10) [MIM:610283]. CORDs are inherited retinal dystrophies belonging to the group of pigmentary retinopathies. CORDs are characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa.
Similarity : Belongs to the semaphorin family.
Contains 1 Ig-like C2-type (immunoglobulin-like) domain.
Contains 1 PSI domain.
Contains 1 Sema domain.
實(shí)驗(yàn)流程：
全、新、優(yōu)、品、好四大特點(diǎn)：
跨膜蛋白SEMA4A抗體說(shuō)明書(shū) 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
固醇合成急性調(diào)節(jié)蛋白 多克隆抗體 STAR Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
START域含蛋白3 多克隆抗體 STAR3 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
細(xì)胞信號(hào)轉(zhuǎn)導(dǎo)與轉(zhuǎn)錄激活因子1 多克隆抗體 STAT1 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
斯鈣素蛋白1 多克隆抗體 STC1 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
斯鈣素蛋白2 多克隆抗體 STC2 Polyclonal Antibody 700/30ul#1540/100ul#2520/200ul
乙酰輔酶A羧化酶1ACCα抗體 抑制基因UVRAG抗體
去整合素樣金屬蛋白酶12 抑制基因PHLPP抗體
磷酸化乙酰輔酶A羧化酶1ACCα抗體 抑制基因p63α抗體
膜粘連蛋白2受體抗體 抑制基因p53抗體
晚期糖基化終末產(chǎn)物特異性受體抗體 抑制基因P53蛋白抗體（野生型P53）
脂肪酸轉(zhuǎn)運(yùn)蛋白6抗體 1號(hào)染色體開(kāi)放閱讀框168抗體
沉默調(diào)節(jié)蛋白5抗體 1號(hào)染色體開(kāi)放閱讀框167抗體
葡萄糖轉(zhuǎn)運(yùn)蛋白4增強(qiáng)因子抗體 1號(hào)染色體開(kāi)放閱讀框163抗體
微管卷曲蛋白SYNC抗體 1號(hào)染色體開(kāi)放閱讀框162抗體
通道亞基β4抗體 1號(hào)染色體開(kāi)放閱讀框159抗體
百部Stemona sessilifolia (Miq.) Miq Protostemotinine 原百部次堿 169534-85-4 C23H29NO6 ≥98%
遼東楤木皂苷XLicodongcrclicscponinXHPLC≥98%;20mg/支
巴利森苷B Parishin B 62499-28-9 20mg HPLC≥98% 巴利森苷B62499-28-9用于含量測(cè)...
中藥對(duì)照藥材巖黃連121416-200501TLC法鑒別
Bisdemetxoxycurcumin雙去甲氧基姜黃素純度：
跨膜蛋白SEMA4A抗體說(shuō)明書(shū)人參皂苷Rb1 Ginsenoside Rb1 (≥98%,HPLC) 41753-43-9 20MG 標(biāo)準(zhǔn)品
云南松Pinus yunnanensis 13-輕基-8,11,13-羅漢松科三烯-18-酸 61597-83-9 C17H22O3 ≥95% 扶哌噻噸雜質(zhì)D(Y0000067
Morin hydrate桑色素480-16-0;654055-01-3桑黃素20mg/支
Prazepam CIV標(biāo)準(zhǔn)品2955-38-6 500mg
保亭哥納香Goniothalamus griffithii Cinnamyl cinnamate 肉桂酸肉桂醇酯 122-69-0 C18H16O2 ≥96%
技術(shù)外包服務(wù):
★跨膜蛋白SEMA4A抗體說(shuō)明書(shū) 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
